“…Such risk factors are important HAPI predictors for ICU patients, and their inclusion in the risk assessment tools tends to make the estimates more accurate compared to those provided by generalist tools such as Braden, for example, which does not take into account the use of vasopressors or length of stay (Argenti et al, 2020; Miller et al, 2020; Sala et al, 2021). Specific risk scales for HAPI in the ICU, such as Jackson and Cubbin (Higgins et al, 2020), Sanada (Sanada et al, 2008), and CAVE (Ninbanphot et al, 2020), do not consider the time effect of length of stay in the ICU, the period of time under invasive mechanical ventilation, or the period of norepinephrine administration (at most, they consider presence/absence of vasopressor drugs).…”